InvestorsHub Logo
Followers 113
Posts 25553
Boards Moderated 4
Alias Born 02/01/2004

Re: None

Friday, 02/20/2015 4:10:25 PM

Friday, February 20, 2015 4:10:25 PM

Post# of 40492
Inovio Pharmaceuticals Inc Analyst Rating Update

by Thomas Lindt on February 19, 2015

Analysts at Zacks have given a Neutral rating on Inovio Pharmaceuticals Inc (NASDAQ:INO) with a rating of 3. The counter has received an average rating of 1 from 5 brokerage firms. 5 analysts have rated the company as a strong buy.

Inovio Pharmaceuticals Inc (NASDAQ:INO): The mean estimate for the short term price target for Inovio Pharmaceuticals Inc (NASDAQ:INO) stands at $22.2 according to 5 Analysts. But, the investors should remain cautious as the stock may face wide vicissitudes from its mean price; the higher price target estimate for the stock has been calculated at $29 while the lower price target estimate is at $19.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INO News